海圣医疗北交所上市网上路演将于2月3日（星期二）14时在全景路演举行

Core Viewpoint - The company, Zhejiang Haiseng Medical Equipment Co., Ltd., is set to publicly issue shares to unspecified qualified investors and will hold an online roadshow on February 3, 2026, to engage with potential investors [1][2]. Company Overview - Zhejiang Haiseng Medical Equipment Co., Ltd. was established in 2000 and specializes in the research, production, and sales of anesthesia and monitoring medical devices, serving global clinical needs in various departments such as anesthesia, ICU, and emergency [1]. - The company is recognized as one of the early technology-driven medical device manufacturers in China focusing on anesthesia and monitoring consumables, and it has become a leading enterprise in this niche market over the past two decades [1]. Market Presence - The company has built a comprehensive sales network across most provinces and cities in China, with its main products being widely used in over a thousand tertiary hospitals and thousands of medical institutions, including more than 600 top-tier hospitals [2]. - The company has established a strong market reputation and brand recognition, receiving high praise from customers [2]. Stock Issuance Details - The company plans to issue 11,294,118 shares at a price of 12.64 yuan per share, combining targeted placements to strategic investors and online pricing for qualified investors with access to the Beijing Stock Exchange [2]. - The subscription date for the stock issuance is set for February 4, 2026, with the stock code being 920166 and the stock name being Haiseng Medical [2].